Strive Compounding Pharmacy alleges the two pharma companies are coordinating an effort to restrict compounded access.

A compounding pharmacy has filed a lawsuit accusing Eli Lilly and Novo Nordisk of using anticompetitive tactics to prevent it ...

Compounding pharmacy sues Eli Lilly and Novo Nordisk alleging antitrust violations to restrict compounded GLP-1 medication access and limit competition.

Strive Specialities Inc., a major provider of compounded medicines, filed a federal lawsuit against pharmaceutical giants Eli ...

The FDA delayed reviews of two drugs chosen for the Trump administration's new fast-track program after agency scientists ...

Kazmira Pharmacy operates a first-of-its-kind prescription cannabinoid (CBD) therapy platform, built for the healthcare system -- not the wellness aisle. Operating under licensed 503A pharmacy ...

Unlike conventional pharmacies, which mostly dispense premade drugs in standard doses, compounding pharmacies make, or "compound," medications on the premises, according to federal guidelines. For ...

Strive Compounding Pharmacy alleged in its lawsuit that Eli Lilly and Novo Nordisk have worked to lock telehealth providers ...

LOUISVILLE, Ky. (WDRB) -- A nationwide shortage of popular weight loss medications has patients searching for alternatives, and many are turning to compounded versions. However, not all options are ...

Lawsuit alleges anti-competitive conduct designed to suppress lawful compounding pharmaceuticals and limit patient choice ...